Showing 21 - 30 of 79
Persistent link: https://www.econbiz.de/10005238610
We consider the estimation of the parameters indexing a parametric model for the conditional distribution of a diagnostic marker given covariates and disease status. Such models are useful for the evaluation of whether and to what extent a marker's ability to accurately detect or discard disease...
Persistent link: https://www.econbiz.de/10005082025
Persistent link: https://www.econbiz.de/10007292877
Persistent link: https://www.econbiz.de/10010605433
We present new statistical analyses of data arising from a clinical trial designed to compare two-stage dynamic treatment regimes (DTRs) for advanced prostate cancer. The trial protocol mandated that patients be initially randomized among four chemotherapies, and that those who responded poorly...
Persistent link: https://www.econbiz.de/10010605448
Persistent link: https://www.econbiz.de/10008723904
We consider estimation, from a double-blind randomized trial, of treatment effect within levels of base-line covariates on an outcome that is measured after a post-treatment event <b>E</b> has occurred in the subpopulation <scriptface>P</scriptface><sub><b>E,E</b></sub> that would experience event <b>E</b> regardless of treatment. Specifically, we...
Persistent link: https://www.econbiz.de/10005140187
Persistent link: https://www.econbiz.de/10010683916
Standardized means, commonly used in observational studies in epidemiology to adjust for potential confounders, are equal to inverse probability weighted means with inverse weights equal to the empirical propensity scores. More refined standardization corresponds with empirical propensity scores...
Persistent link: https://www.econbiz.de/10009148382
Persistent link: https://www.econbiz.de/10008784043